Latest News & Updates
Breaking News
1 day ago
Vaibhavi M.
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Azurity Pharmaceuticals Acquires Matinas BioPharma LNC Platform in Deal Worth Up to $21.5M
Azurity Pharmaceuticals acquires Matinas BioPharma's LNC platform and MAT2203 for up to $21.5M, signaling a formulation technology transfer with GMP and regulatory implications.
Vaibhavi M.
CLINUVEL Gains Health Canada NOC for SCENESSE in Rare Photoprotection Indication
Health Canada issues NOC for CLINUVEL's SCENESSE® in EPP, backed by post-marketing data from three prior regulatory approvals.
Vaibhavi M.
Sun Pharma Achieves Rs. 33,500 Crore Cumulative R&D Investment Targeting Global Specialty Pipeline
Sun Pharma's Rs. 33,500 crore cumulative R&D spend raises near-term demands on process validation, tech transfer, and global regulatory submissions.
Pharma Now Editorial Team
NATCO Pharma Acquires 49% Stake in Adcock Ingram in Rs. 1,069 Crore Deal
NATCO Pharma raises its Adcock Ingram stake to 49% in a Rs. 1,069 crore deal, triggering dual SAHPRA-CDSCO compliance requirements.
Pharma Now Editorial Team
